TipRanks
Go Ultimate55% OFF

Dianthus Therapeutics (DNTH) Revenue

445 Followers

Dianthus Therapeutics Revenue

Dianthus Therapeutics had a revenue of 1.21M in the quarter ending Sep 30, 2026, with 59.00%. This bring the company's revenue in the last twelve months to 2.72M, Increased 42.75%. In the fiscal year ending Dec 31, 2025, Dianthus Therapeutics had annual revenue of 2.04M with -67.35% growth.

Revenue (ttm)
2.72M
Revenue Growth
-11.70%
P/S Ratio
2357.43
Revenue/Employee
$22,130
Employees
92
Market Cap
$4.80B

Revenue Chart

Dianthus Therapeutics Revenue - Annual

02M4M6M8M1.48M6.42M2.83M6.24M2.04M201720182019202020212022202320242025
Revenue History
Download to Excel
DNTH revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20252.04M-4.20M-67.35%
Dec 31, 20246.24M3.41M120.63%
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M1.48M―
Dec 31, 20200.000.00―
Dec 31, 20190.000.00―
Dec 31, 20180.000.00―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DNTH2.72M
OMER38.42M
TVTX651.03M
VRDN26.31M
NAMS25.94M
VERA10.28M